Juan Coves

SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015

Rosario García‐Campelo, Reyes Bernabé, Manuel Cobo et al. · Clinical & Translational Oncology · 2015 · 54 citations · Full text

Medicine, Molecular Medicine, Oncology +12

Analysis of circulating tumour DNA to identify patients with epidermal growth factor receptor–positive non-small cell lung cancer who might benefit from sequential tyrosine kinase inhibitor treatment

Roberto Serna‐Blasco, V. Blázquez Calvo, Ana Royuela et al. · European Journal of Cancer · 2021 · 34 citations · Full text

Medicine, Oncology, Pharmacology +16

Patient preference for oral chemotherapy in the treatment of metastatic breast and lung cancer

Eva Ciruelos, María Nieves Perejón Díaz, Rafael López‐López et al. · European Journal of Cancer Care · 2019 · 28 citations

Medicine, Oncology, Pharmacotherapy +16

Phase II clinical trial with metronomic oral vinorelbine and tri-weekly cisplatin as induction therapy, subsequently concomitant with radiotherapy (RT) in patients with locally advanced, unresectable, non-small cell lung cancer (NSCLC). Analysis of survival and value of ctDNA for patient selection

Mariano Provencio, Margarita Majem, M. Guirado et al. · Lung Cancer · 2021 · 25 citations

Medicine, Oncology, Pharmacology +17

Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group

Josefa Terrasa, Pilar Garrido, Rosario García Campelo et al. · BMC Cancer · 2021 · 16 citations · Full text

Pharmacy, Oncology, Pharmacology +15